Parkinson’s disease biomarkers in human olfactory cleft mucus
Objective: To investigate and identify biomarkers for PD from human olfactory cleft mucus Background: Olfactory loss is an early symptom of PD, often preceding motor…The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder
Objective: 1. To determine the co-occurrence rate of PTSD in veterans with PD and RBD.2. To evaluate severity of dream enactment behavior (DEB) and rate…Influence of Fatigue in Parkinson’s Disease on Variability of Gait Measures
Objective: This project aims to explore the experience of fatigue in Parkinson’s patients, and its influence on gait variability in stride frequency and ground contact…Obsessive-Compulsive Disorder Prevalence in Parkinson’s Disease Caregivers
Objective: Our goal is to assess the prevalence of obsessive-compulsive disorder (OCD) among those who provide care for individuals with Parkinson's disease (PD). Additionally, we…Functional Motor Disorders in pediatrics: motor patterns and clinical correlates.
Objective: The aim of this study was to describe FMDs clinical manifestations in pediatrics, including non-motor symptoms and other functional neurological disorders (FNDs) and to…Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy
Objective: We describe a patient who developed amantadine-induced craniofacial myoclonus with speech impairment. Few cases have been reported [1], thus we offer an additional case…Validation of PD Ascertainment in the VA Electronic Medical Record (EMR)
Objective: To determine the validity of PD diagnostic codes in a large national electronic medical database and develop recommendations for maximizing ascertainment accuracy. Background: EMR-based…Prevalence of Advanced Parkinson’s Disease and Potential Candidacy for Device-Aided Therapies in the Casablanca Region: Preliminary Results of a Multicenter Regional Study
Objective: This preliminary study aims to investigate the prevalence of advanced Parkinson's disease (PD) among patients receiving treatment in the Casablanca region of Morocco. Background:…No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence
Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.